These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4005123)

  • 1. Gastrointestinal transit of Oros drug delivery systems in healthy volunteers: a short report.
    John VA; Shotton PA; Moppert J; Theobald W
    Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):203S-206S. PubMed ID: 4005123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of oxprenolol and metoprolol Oros systems in the dog: comparison of in vivo and in vitro drug release, and of drug absorption from duodenal and colonic infusion sites.
    Fara JW; Myrback RE; Swanson DR
    Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):91S-95S. PubMed ID: 4005134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reproducibility of oxprenolol plasma concentrations in young female volunteers following oral administration of an oxprenolol Oros dosage form.
    Jack DB; Kendall MJ; Laugher SJ; Smith SR
    Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):185S-190S. PubMed ID: 4005121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between the rate of appearance of oxprenolol in the systemic circulation and the location of an oxprenolol Oros 16/260 drug delivery system within the gastrointestinal tract as determined by scintigraphy.
    Davis SS; Washington N; Parr GD; Short AH; John VA; Lloyd P; Walker SM
    Br J Clin Pharmacol; 1988 Oct; 26(4):435-43. PubMed ID: 3056482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osmotic delivery systems for the beta-adrenoceptor antagonists metoprolol and oxprenolol: design and evaluation of systems for once-daily administration.
    Theeuwes F; Swanson DR; Guittard G; Ayer A; Khanna S
    Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):69S-76S. PubMed ID: 4005132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic investigation of the absorption of oxprenolol from Oros delivery systems in healthy volunteers: comparison of in vivo and in vitro drug release.
    Bradbrook ID; John VA; Morrison PJ; Rogers HJ; Spector RG
    Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):163S-169S. PubMed ID: 4005118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of site of drug delivery on the systemic availability of metoprolol: comparison of intragastric infusion and 14/190 Oros administration.
    Warrington SJ; Barclay SP; John VA; Shotton PA; Wardle HM; Good W
    Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):219S-224S. PubMed ID: 4005126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oros drug delivery systems for the beta-adrenoreceptor antagonists oxprenolol and metoprolol.
    Br J Clin Pharmacol; 1985; 19 Suppl 2():63S-249S. PubMed ID: 4005131
    [No Abstract]   [Full Text] [Related]  

  • 9. A multiple dose comparative study of the pharmacodynamic and pharmacokinetic behaviour of polymer-matrix and Oros dosage forms of oxprenolol in healthy volunteers.
    Woods KL; Jack DB; Kendall MJ; Halsey A; O'Donnell ML; Warrington SJ; John VA
    Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):177S-184S. PubMed ID: 4005120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-dose pharmacokinetic and pharmacodynamic comparison of polymer-matrix (Slow Trasicor) and Oros dosage forms of oxprenolol in healthy volunteers.
    Bennett PN; Bennett J; Bradbrook I; Francis J; John VA; Rogers H; Turner P; Warrington SJ
    Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):171S-175S. PubMed ID: 4005119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osmotically controlled-delivery of metoprolol in man: in vivo performance of Oros systems with different durations of drug release.
    Godbillon J; Gerardin A; Richard J; Leroy D; Moppert J
    Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):213S-218S. PubMed ID: 4005125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacokinetics of oxprenolol following oral and rectal dosing--a comparison of delivery systems and routes of administration.
    Gregg MR; Jack DB; Smith SR; Kendall MJ
    J Clin Pharm Ther; 1987 Apr; 12(2):91-9. PubMed ID: 3584272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of single-dose pharmacokinetic and pharmacodynamic properties of two metoprolol Oros systems with different initial zero-order release rates.
    Warrington SJ; Barclay SP; John VA; Shotton PA; Good W
    Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):225S-230S. PubMed ID: 4005127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multiple dose pharmacokinetic and pharmacodynamic evaluation of conventional and 19/285 Oros formulations of metoprolol in healthy volunteers.
    Grainger SL; John VA; Shotton PA; Smith SE
    Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):239S-244S. PubMed ID: 4005129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of food intake on plasma oxprenolol concentrations following oral administration of conventional and Oros preparations.
    John VA; Smith SE
    Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):191S-195S. PubMed ID: 4005122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo deconvolution assessment of drug release kinetics from oxprenolol Oros preparations.
    Langenbucher F; Mysicka J
    Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):151S-162S. PubMed ID: 4005117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of plasma and saliva levels of metoprolol and oxprenolol.
    Dawes CP; Kendall MJ; John VA
    Br J Clin Pharmacol; 1978 Mar; 5(3):217-21. PubMed ID: 656265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stable isotope methodology for studying the performance of metoprolol Oros tablets in comparison to conventional and slow release formulations.
    Richard J; Cardot JM; Godbillon J
    Eur J Drug Metab Pharmacokinet; 1994; 19(4):375-80. PubMed ID: 7737240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of pharmacokinetic profiles of single and multiple doses of a slow release Oros oxprenolol delivery system in young normotensive and elderly hypertensive subjects.
    Bradbrook ID; Babiker M; Crome P; Gillies HC; Morrison PJ; Rogers HJ; Shotton P
    Br J Clin Pharmacol; 1986 Apr; 21(4):371-6. PubMed ID: 3707811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of food on the absorption of metoprolol administered as an Oros drug delivery system to man.
    Lecaillon JB; Massias P; Schoeller JP; Abadie F
    Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):245S-249S. PubMed ID: 4005130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.